Austin Liu, MD
Dermatology · Doylestown, PANPI 1679735351
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,146 of the $12,748 with a category attached, or 63.9%. 23 manufacturers reported payments, led by Regeneron at 37.0% of the total. 2025 is the largest year on record at $6,373, 7.6 times the $835 reported in 2019.
Across 276 payments — averaging $46.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$5K
- Johnson & Johnson$3K
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Janssen Scientific Affairs, LLC$893
- Sun Pharmaceutical Industries Inc.$323
- plus $1K from 17 others
What the payments were for
- Consulting fees$4,52535%
- Travel & lodging$771%
- Food & beverage$8,14664%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 6 | $4,716 |
| Johnson & Johnson | 121 | $3,171 |
| AbbVie(2 entities) | 71 | $1,551 |
| Regeneron Healthcare Solutions, Inc. | 26 | $1,001 |
| Janssen Scientific Affairs, LLC | 8 | $893 |
| Sun Pharmaceutical Industries Inc. | 7 | $323 |
| LEO Pharma Inc. | 3 | $146 |
| Incyte Corporation | 5 | $128 |
| Organon | 1 | $126 |
| UCB, Inc. | 4 | $94 |
| Sanofi | 3 | $93 |
| Misonix Inc | 3 | $87 |
| Amgen | 4 | $83 |
| Lilly USA, LLC | 4 | $79 |
| Prugen, Inc. Pharmaceuticals | 1 | $67 |
| Lifenet Health | 1 | $44 |
| Organogenesis Inc. | 1 | $36 |
| Biofrontera Inc. | 2 | $26 |
| Novartis | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Mimedx Group, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,748 in reported general payments places this provider in the 85th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 153 | $5,260 |
| Doxycycline Hyclate | 150 | $741 |
| Triamcinolone Acetonide | 21 | $269 |
| Clobetasol Propionate | 12 | $209 |
| Ketoconazole | 11 | $161 |
| Mupirocin | 12 | $106 |
| Cephalexin | 28 | $39 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Doylestown
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Adel HaqueYardley$1M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.